Details for 2014722018
Up to date per 02.04.2026
Actions
Details for 2014722018
Granted/Registered
European Patent
20.01.2016 A
23.08.2017 B1
14.03.2013
US
201361782531 P
20.06.2013
US
201361837399 P
15.11.2013
US
201361904579 P
06.12.2013
US
201361912777 P
20.02.2014
US
201461942367 P
C12N 15/113 20100101AFI20151014BHEP
Owner
Alnylam Pharmaceuticals, Inc.300 Third Street, 3rd Floor Cambridge, MA 02142US
Representative
Representative
HÄUPL & ELLMEYER KG PATENTANWALTSKANZLEIMariahilfer Straße 501070 WienAT
Inventor
FITZGERALD, Kevin300 Third Street 3rd Floor Cambridge, MA 02142US
BUTLER, James300 Third Street 3rd Floor Cambridge, MA 02142US
BETTENCOURT, Brian300 Third Street 3rd Floor Cambridge, MA 02142US
BORODOVSKY, Anna300 Third Street 3rd Floor Cambridge, MA 02142US
KUCHIMANCHI, Satyanarayana300 Third Street 3rd Floor Cambridge, MA 02142US
CHARISSE, Klaus300 Third Street 3rd Floor Cambridge, MA 02142US
MANOHARAN, Muthiah300 Third Street 3rd Floor Cambridge, MA 02142US
MAIER, Martin300 Third Street 3rd Floor Cambridge, MA 02142US
RAJEEV, Kallanthottathil, G.300 Third Street 3rd Floor Cambridge, MA 02142US
FOSTER, Donald300 Third Street Cambridge, MA 02142US
Information about Fees